The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: https://twitter.com/rowpower.
J Am Coll Cardiol. 2021 Nov 30;78(22):2196-2212. doi: 10.1016/j.jacc.2021.09.859.
Myocardial bridging (MB) is a congenital coronary anomaly in which a segment of the epicardial coronary artery traverses through the myocardium for a portion of its length. The muscle overlying the artery is termed a myocardial bridge, and the intramyocardial segment is referred to as a tunneled artery. MB can occur in any coronary artery, although is most commonly seen in the left anterior descending artery. Although traditionally considered benign in nature, increasing attention is being given to specific subsets of MB associated with ischemic symptomatology. The advent of contemporary functional and anatomic imaging modalities, both invasive and noninvasive, have dramatically improved our understanding of dynamic pathophysiology associated with MBs. This review provides a contemporary overview of epidemiology, pathobiology, diagnosis, functional assessment, and management of MBs.
心肌桥(MB)是一种先天性冠状动脉异常,其中一段心外膜冠状动脉在其长度的一部分穿过心肌。覆盖在动脉上的肌肉称为心肌桥,而位于心肌内的部分称为隧道样动脉。MB 可发生于任何冠状动脉,但最常见于左前降支。尽管传统上认为 MB 是良性的,但越来越多的人关注与缺血症状相关的特定 MB 亚组。现代功能和解剖成像技术的出现,包括有创和无创的,极大地提高了我们对 MB 相关动态病理生理学的理解。本文综述了 MB 的流行病学、病理生物学、诊断、功能评估和治疗的最新进展。